MELAGLOW CREAM 30 GM

Melaglow Cream 30gm is a topical cream used to treat hyperpigmentation conditions such as melasma, sunspots, and post-inflammatory hyperpigmentation.

The main ingredients in Melaglow Cream 30gm typically include a combination of hydroquinone, tretinoin, and mometasone furoate.

Apply a small amount of the cream to the affected area, usually at night, and as directed by your doctor.

Common side effects may include redness, dryness, burning, itching, or peeling of the skin.

It is important to consult a doctor before using Melaglow Cream 30gm during pregnancy as it contains ingredients that may harm the developing fetus.

Melaglow Cream 30gm is primarily used to treat hyperpigmentation, but it may have some effect on acne due to the presence of tretinoin.

Long-term use of Melaglow Cream 30gm is not recommended as it can lead to side effects and thinning of the skin. It should only be used under the guidance of a doctor.

Store Melaglow Cream 30gm at room temperature, away from direct sunlight and heat.

Yes, Melaglow Cream 30gm can make the skin more sensitive to the sun. Therefore, it is important to use sunscreen and avoid unnecessary sun exposure.

In case of an overdose of Melaglow Cream 30gm, contact a doctor immediately or go to the nearest hospital.

Melaglow Cream 30gm may interact with other topical medications or cosmetics. Therefore, it is important to inform your doctor about all the products you are using.

Melaglow Cream 30gm may not be suitable for all skin types. People with sensitive skin should use it with caution.

Melaglow Cream 30gm is usually recommended to be applied at night because it can make the skin more sensitive to the sun.

If you forget to apply Melaglow Cream 30gm, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Yes, Melaglow Cream 30gm contains hydroquinone, which helps in lightening skin tone and reducing hyperpigmentation.

Melaglow cream is primarily used to help reduce hyperpigmentation and improve overall skin tone. It is commonly recommended as an adjunctive topical product in conditions such as melasma, post-inflammatory hyperpigmentation (for example after acne or minor procedures), sun-induced dark spots, and general uneven skin tone. It is intended for external use on affected areas of the skin, usually the face, under the guidance of a dermatologist or healthcare professional.

Melaglow cream typically contains niacinamide (vitamin B3) and licorice extract, among other ingredients. Niacinamide helps reduce the transfer of melanin from pigment-producing cells (melanocytes) to surrounding skin cells, which can gradually lighten dark patches. Licorice extract contains compounds that inhibit tyrosinase, a key enzyme in melanin synthesis, and also has anti-inflammatory and antioxidant properties. Together, these actions help reduce excessive pigmentation and promote a more even skin tone when used regularly with sun protection.

The onset of visible benefit from Melaglow cream is gradual. Many individuals may start noticing subtle improvement in skin tone and lightening of dark spots after several weeks of consistent use, but more pronounced changes often require 8 to 12 weeks or longer. The exact time frame varies depending on the severity and cause of pigmentation, skin type, adherence to treatment, and the use of adequate sun protection. If there is no noticeable improvement after a few months, or if pigmentation worsens, a dermatologist should be consulted for reassessment.

Melaglow cream is generally suitable for a wide range of skin types, including oily, combination, and normal skin. Many people with dry or sensitive skin can also use it, but they may be more prone to irritation, especially at the start of therapy. In such cases, a dermatologist may advise adjusting the frequency of application or combining it with a suitable moisturizer. A patch test on a small area is advisable for individuals with a history of cosmetic allergies or very reactive skin.

Melaglow cream does not typically contain topical corticosteroids or strong depigmenting drugs such as high-strength hydroquinone, which are associated with more significant long-term risks. When used as directed, it is generally considered suitable for extended use as part of a maintenance regimen for hyperpigmentation. However, long-term use should still be periodically reviewed by a dermatologist to ensure ongoing benefit, monitor for irritation or allergy, and adjust the overall treatment plan as needed.

Melaglow cream is not designed to bleach or drastically change the natural baseline color of normal skin. Its primary role is to reduce excessive or patchy pigmentation so that the skin tone appears more even. In practice, it tends to have a more noticeable effect on darker or hyperpigmented areas than on surrounding normal skin. It should not be used with the intention of achieving overall skin whitening beyond one’s natural complexion.

Melaglow cream can usually be incorporated into a broader skincare routine that includes a gentle cleanser, moisturizer, and broad-spectrum sunscreen. It may also be used alongside other dermatologist-prescribed treatments, such as retinoids or chemical exfoliants, if specifically advised. However, combining multiple active products without professional guidance can increase the risk of irritation, dryness, or barrier damage. It is advisable to discuss your full skincare regimen with a dermatologist before adding or layering Melaglow cream with other active agents.

Most side effects of Melaglow cream are local and mild. They may include transient burning, stinging, itching, redness, dryness, or a feeling of tightness at the application site, particularly during the initial days of use. In some individuals, especially those with sensitive skin, more pronounced irritation or allergic contact dermatitis can occur, presenting as persistent redness, swelling, intense itching, or rash. If severe irritation, blistering, or worsening pigmentation develops, use should be stopped and medical advice sought promptly.

Data on the use of Melaglow cream specifically in pregnancy and breastfeeding are limited. Its key ingredients, such as niacinamide and licorice extract, are generally considered low risk when used topically in typical cosmetic concentrations, but robust controlled studies in pregnant or breastfeeding women are lacking. Because melasma and pigmentation changes are common in pregnancy, many clinicians prefer conservative, non-irritating regimens and strict sun protection. Pregnant or breastfeeding individuals should consult their obstetrician or dermatologist before starting Melaglow cream to ensure that its use is appropriate in their particular situation.

Yes. Consistent use of a broad-spectrum sunscreen is essential when using Melaglow cream or any depigmenting product. Ultraviolet and visible light exposure can worsen hyperpigmentation and counteract the benefits of treatment. Daily application of a suitable sunscreen, reapplication as needed, and additional protective measures such as hats and shade-seeking are critical to achieving and maintaining improvement. Without adequate sun protection, the benefits of Melaglow cream are likely to be limited and pigmentation may recur or intensify.